Abbott is marching to the beat of a very profitable drum, driven by cardiac care dominance, nutrition brand power, and ...

Abbott (ABT) closed the most recent trading day at $131.30, moving -0.15% from the previous trading session. This move was narrower than the S&P 500's daily loss of 0.67%. Elsewhere, the Dow saw a ...

Abbott Laboratories (NYSE:ABT) made headlines with its commercial development agreement to integrate advanced diabetes management technology with Sequel Med Tech, aiming to improve outcomes for ...

These four Dividend Aristocrats have far outperformed the S&P 500 so far this year, but they still offer investors good entry ...

With both MDT & ABT focusing on their core strengths, the stage is set for a compelling comparison. Let's see which stock is ...

Abbott boasts strong profitability, stable margins, and impressive long-term growth, but recent sales have stagnated. Check ...

Operating margin of Abbott India significantly improved, widened by 434 bps to 26.7% in Q4 FY25 from 22.9% a year ago quarter.

Citing what they call the S&P 500 price-to-earnings mania, Stifel is once again recommending that what it calls “defensive ...

Abbott has officially upgraded its medical resume from glucose guru to heart hero. Its FreeStyle Libre device is now linked ...

Abbott Laboratories (NYSE:ABT) recently shared findings from its REFLECT real-world studies, revealing that the use of its ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.